![](/img/cover-not-exists.png)
First-line treatment with abciximab does not reduce mortality or myocardial infarction in people with acute coronary syndromes not undergoing early revascularization
Christopher P CannonVolume:
5
Year:
2001
Language:
english
DOI:
10.1054/ebcm.2001.0418
File:
PDF, 238 KB
english, 2001